Definitive Healthcare (DH) Net Income towards Common Stockholders (2020 - 2026)

Definitive Healthcare (DH) has reported Net Income towards Common Stockholders for 7 consecutive years, with -$7.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 19.57% year-over-year to -$7.5 million; the trailing twelve-month figure through Jun 2026 stood at -$200.8 million (up 54.05% YoY), and the FY2025 full-year result was -$165.3 million, up 72.05% from the prior year.
• Net Income towards Common Stockholders rose to -$7.5 million in Q2 2026 per DH's latest filing, from -$192.4 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $16.8 million in Q4 2025 and bottomed at -$306.2 million in Q2 2024.
• Historically, Net Income towards Common Stockholders has averaged -$70.6 million across 5 years, with a median of -$13.2 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders soared 138.97% in 2022, then slumped 3512.03% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at $5.9 million in 2022, then tumbled by 326.97% to -$13.4 million in 2023, then tumbled by 534.01% to -$84.7 million in 2024, then surged by 119.87% to $16.8 million in 2025, then plunged by 144.26% to -$7.5 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$7.5 million, -$192.4 million, and $16.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.